2000
DOI: 10.1111/j.1469-7793.2000.00225.x
|View full text |Cite
|
Sign up to set email alerts
|

Single‐channel analysis of an NMDA receptor possessing a mutation in the region of the glutamate binding site

Abstract: Recombinant NR1a/NR2A(T671A) N‐methyl‐D‐aspartate (NMDA) receptor‐channels, which carry a point mutation in the putative glutamate binding site that reduces glutamate potency by around 1000‐fold, have been expressed in Xenopus laevis oocytes and their single‐channel properties examined using patch‐clamp recording techniques. Shut time distributions of channel activity were fitted with a mixture of five exponential components. The first three components in each distribution were considered to occur within a cha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
27
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(37 citation statements)
references
References 28 publications
(45 reference statements)
9
27
1
Order By: Relevance
“…Previous studies have characterized the properties of glutamate-activated NR1/NR2A(T671A) receptors and the homologous mutation in NR2D-containing NMDA receptors at both the whole-cell and single-channel level (Anson et al, 1998(Anson et al, , 2000Chen et al, 2004). In the present study, we find that the potencies for all four agonists were decreased by this mutation, with effects on glutamate potency being the largest (848-fold; Table 1).…”
Section: Mutation Of Contact Residues In the S2supporting
confidence: 57%
See 1 more Smart Citation
“…Previous studies have characterized the properties of glutamate-activated NR1/NR2A(T671A) receptors and the homologous mutation in NR2D-containing NMDA receptors at both the whole-cell and single-channel level (Anson et al, 1998(Anson et al, , 2000Chen et al, 2004). In the present study, we find that the potencies for all four agonists were decreased by this mutation, with effects on glutamate potency being the largest (848-fold; Table 1).…”
Section: Mutation Of Contact Residues In the S2supporting
confidence: 57%
“…Several structure-function studies of ionotropic glutamate receptors and related kainate binding proteins have identified residues located in the S1 and S2 binding domains that, when mutated, lead to a reduction in the ability of the ligand to remain bound to its binding site (Kuryatov et al, 1994;Kuusinen et al, 1995;Paas et al, 1996;Laube et al, 1997Laube et al, , 2004Anson et al, 1998Anson et al, , 2000Wo et al, 1999;Kalbaugh et al, 2004; for review, see Erreger et al, 2004). This study is the first to describe systematically the effects of mutating each of the proposed contact residues in the ligand binding Fig.…”
Section: Discussionmentioning
confidence: 99%
“…This surprising effect is conserved in rat ASIC1a, human ASIC1a (hASIC1a), and chicken ASIC1a (cASIC1a), but is not seen in rat ASIC1a/2a heteromers. From a biophysical perspective, our findings are unexpected because, classically, deactivation kinetics are independent of agonist concentration (32)(33)(34)(35)(36). In addition, these findings are physiologically intriguing because they indicate that synaptic ASIC1a could shift between very fast AMPA-like kinetics and slower NMDA-like kinetics depending on the recent history of the synapse.…”
contrasting
confidence: 41%
“…Notwithstanding, this study is the first to report equilibrium constants for NVP-AAM077 action at NR1/NR2A and NR1/NR2B NMDA receptors and to demonstrate that its action is indeed competitive in nature and is surmountable by increasing the concentration of glutamate used to activate receptors. In addition, our results show that at least one of the residues (Thr671) that interacts directly with glutamate in the ligand binding domain (for review, see Chen and Wyllie, 2006; also see Anson et al, 1998Anson et al, , 2000Chen et al, 2004Chen et al, , 2005Furukawa et al, 2005) also influences NVP-AAM077 binding. The NR2A(T671A) mutation has previously been shown to reduce D-AP5 potency (Anson et al, 1998), suggesting that this residue plays an important role in competitive antagonist binding as well as agonist binding in NR2A NMDA receptor subunits.…”
Section: Discussionmentioning
confidence: 80%